Choroidal neovascularization secondary to sorsby fundus dystrophy treated with intravitreal bevacizumab.
To report a case of extrafoveal choroidal neovascularization secondary to Sorsby fundus dystrophy that maintained 20/20 visual acuity over 14 months with intravitreal bevacizumab therapy. Interventional case report of as-needed treatment with intravitreal bevacizumab of a 38-year-old lady with choroidal neovascularization from Sorsby fundus dystrophy. Three injections of intravitreal bevacizumab were given over 14.5 months, maintaining visual acuity at 20/20. Intravitreal bevacizumab therapy appears to maintain vision in patients with choroidal neovascularization from Sorsby fundus dystrophy.